Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
  2. >
  3. Stock
  4. >
  5. NEPH
stocks logo

NEPH

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Intellectia AI SwingMax
Intellectia AI SwingMax

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
4.45M
+15.01%
0.010
-66.67%
5.14M
+5.31%
0.040
-20%
4.85M
+9.82%
0.020
0%
Estimates Revision
The market is revising Downward the revenue expectations for Nephros, Inc. (NEPH) for FY2025, with the revenue forecasts being adjusted by -0.27% over the past three months. During the same period, the stock price has changed by 51.04%.
Revenue Estimates for FY2025
Revise Downward
down Image
-0.27%
In Past 3 Month
EPS Estimates for FY2025
No Change
down Image
0.00%
In Past 3 Month
Stock Price
Go Up
up Image
+51.04%
In Past 3 Month
Wall Street analysts forecast NEPH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NEPH is 8.00 USD with a low forecast of 8.00 USD and a high forecast of 8.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
Wall Street analysts forecast NEPH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NEPH is 8.00 USD with a low forecast of 8.00 USD and a high forecast of 8.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 5.785
sliders
Low
8.00
Averages
8.00
High
8.00
Current: 5.785
sliders
Low
8.00
Averages
8.00
High
8.00
Maxim
Maxim
NULL -> Buy
upgrade
$6
2025-08-08
Reason
Maxim
Maxim
Price Target
$6
2025-08-08
upgrade
NULL -> Buy
Reason
Maxim raised the firm's price target on Nephros to $6 from $4.50 and keeps a Buy rating on the shares. The company's Q2 results saw revenue, gross margins, and earnings all above consensus estimates, the analyst tells investors in a research note.
See All Ratings

Valuation Metrics

The current forward P/E ratio for Nephros Inc (NEPH.O) is 45.00, compared to its 5-year average forward P/E of -24.94. For a more detailed relative valuation and DCF analysis to assess Nephros Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-24.94
Current PE
45.00
Overvalued PE
104.43
Undervalued PE
-154.31

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-12.81
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
7.82
Undervalued EV/EBITDA
-33.44

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
2.81
Current PS
0.00
Overvalued PS
5.09
Undervalued PS
0.52
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
AI Stock Picker
AI Stock Picker

NEPH News & Events

Events Timeline

(ET)
2025-10-08
09:11:53
Nephros Introduces New Filter for PFAS Removal
select
2024-10-24 (ET)
2024-10-24
09:09:57
Nephros launches HydraGuard 20" UltraFilter
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
9.5
08-09Yahoo Finance
Nephros Inc (NEPH) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Profitability ...
  • Financial Performance: Nephros Inc reported a 36% increase in net revenue for Q2 2025, reaching $4.4 million, with improved gross margins of 63% and a positive net income of $237,000, marking its third consecutive profitable quarter.

  • Strategic Initiatives: The company's growth was driven by a filter tracking app and service initiatives that enhanced customer reordering behavior, while it aims to expand into underserved verticals despite challenges in salesforce adequacy and maintaining operational discipline.

[object Object]
Preview
4.0
08-09Benzinga
Maxim Group Maintains Buy on Nephros, Raises Price Target to $6
  • Fastest News Alerts: Benzinga Pro offers real-time intelligence and news alerts to help traders stay informed and make winning trades in the stock market.

  • Exclusive Community Access: Joining Benzinga Pro connects users with over 10,000 serious traders and provides access to exclusive stories and insights from Benzinga reporters.

[object Object]
Preview
9.5
07-15Yahoo Finance
Earnings To Watch: Nephros Inc (NEPH) Reports Q2 2025 Result
  • Earnings Release and Estimates: Nephros Inc is scheduled to release its Q2 2025 earnings on July 16, with revenue estimates of $3.65 million and expected earnings of -$0.03 per share. Full year 2025 revenue is projected at $16.25 million, despite a decline in earnings estimates for both 2025 and 2026.

  • Stock Performance and Analyst Ratings: Following a previous quarter where actual revenue exceeded expectations, Nephros Inc's stock has an average target price of $4.75, indicating a potential upside from the current price of $3.78, while GuruFocus suggests a downside based on their estimated GF Value of $2.28.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Nephros Inc (NEPH) stock price today?

The current price of NEPH is 5.785 USD — it has increased 7.13 % in the last trading day.

arrow icon

What is Nephros Inc (NEPH)'s business?

Nephros, Inc. is a water technology company providing filtration solutions to the medical and commercial markets. The Company provides water filtration products and services, along with water-quality education. In the medical markets, it sells water filtration products. In the commercial market, it manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, heavy metals, chemical compounds, scale build-up in downstream equipment, and various other contaminants. Its products are marketed primarily to the food service, hospitality, convenience store, and healthcare markets. These commercial products are also marketed in medical markets as supplemental filtration to its medical filters. Its filters are primarily used in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, and in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate.

arrow icon

What is the price predicton of NEPH Stock?

Wall Street analysts forecast NEPH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NEPH is 8.00 USD with a low forecast of 8.00 USD and a high forecast of 8.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Nephros Inc (NEPH)'s revenue for the last quarter?

Nephros Inc revenue for the last quarter amounts to 4.76M USD, increased 35.42 % YoY.

arrow icon

What is Nephros Inc (NEPH)'s earnings per share (EPS) for the last quarter?

Nephros Inc. EPS for the last quarter amounts to 0.03 USD, increased 50.00 % YoY.

arrow icon

What changes have occurred in the market's expectations for Nephros Inc (NEPH)'s fundamentals?

The market is revising Downward the revenue expectations for Nephros, Inc. (NEPH) for FY2025, with the revenue forecasts being adjusted by -0.27% over the past three months. During the same period, the stock price has changed by 51.04%.
arrow icon

How many employees does Nephros Inc (NEPH). have?

Nephros Inc (NEPH) has 31 emplpoyees as of December 05 2025.

arrow icon

What is Nephros Inc (NEPH) market cap?

Today NEPH has the market capitalization of 61.48M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free